Hypolipidemic effect of phenolic antioxidants

M. L. Belen'kii, Elements of Quantitative Evaluation of a Pharmacologic Effect [in Russian], Leningrad (1963).Google Scholar

V. I. Kalmykova, in: Oxidoreduction, Atherogenesis, and Ischemic Heart Disease [in Russian], Novokuznetsk (1975), p. 47.Google Scholar

V. Z. Lankin, Kardiologiya, No. 8, 42 (1980).Google Scholar

V. Z. Lankin, A. N. Zakorova, L. V. Kasatkina, et al., Kardiologiya, No. 10, 69 (1979).Google Scholar

T. S. Neustroeva, in: Problems in the General Pathology of Chronic Processes under Clinical and Experimental Conditions [in Russian], Novosibirsk (1977), p. 73.Google Scholar

T. S. Neustroeva and S. V. Mishina, in: Problems in the General Pathology of Chronic Processes under Clinical and Experimental Conditions [in Russian], Novosibirsk (1977), p. 78.Google Scholar

A. A. Pokrovskii (editor), Biochemical Methods of Investigation in Clinical Medicine (Reference Book) [in Russian], Moscow (1969).Google Scholar

S. F. Terekhova, E. B. Burlakova, and T. I. Elizarova, Vopr. Med. Khim. No. 3, 375 (1977).Google Scholar

W. Bai and S. Krishnamurthy, Indian J. Biochem.,16, 249 (1979).Google Scholar

G. H. Bragdon, P. W. Suderman, and F. W. Suderman, in: Lipids and Steroid Hormones in Clinical Medicine, Saunders, Philadelphia (1960), p. 7.Google Scholar

T. Y. Dormandy, Lancet,1, 647, (1978).Google Scholar

R. B. Wilson, C. C. Middleton and G. Y. Sun, J. Nutr.,108, 1858 (1978).Google Scholar

S. J. K. Yousufzai and M. Siddigi, Experientia,32, 1033 (1976).Google Scholar